Exploring extracellular vesicles as novel therapeutic agents for intervertebral disc degeneration: delivery, applications, and mechanisms
Yuxin Jin(Chongqing University), Aimin Wu(Wenzhou Medical University), Kenny Kwan(Chinese University of Hong Kong), Hai Xiang(China Agricultural University), Yan Michael Li(SUNY Upstate Medical University), Pooyan Makvandi(Piaggio (Italy)), Xinzhou Wang(Shijiazhuang University), Qizhu Chen(Wenzhou Medical University), Morgan Jones(Royal Orthopaedic Hospital), Linjie Chen(Fujian Medical University), Kai Zhang(Guizhou University), Jun Zhang(Guizhou Provincial People's Hospital), Zhihua Chen(Shanghai University), Xiangyang Wang(Wenzhou Medical University), Haijun Tian(Shanghai Jiao Tong University), Ouqiang Wu(Children's Hospital of Zhejiang University)
Cited by 10
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
|Nature Genetics|2013|363
Mesenchymal stem cells deliver exogenous miR‐21 <i>via</i> exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration
|Journal of Cellular and Molecular Medicine|2017|316
Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein
|Annals of the Rheumatic Diseases|2018|286